INS and metabolic dysfunction-associated steatotic liver disease: Network pharmacological analysis found that the mechanism of NAFLD remission mainly lies in the main active lignans contained in PET, and these lignans can regulate insulin resistance signaling pathways, thus playing a therapeutic role.